Sarepta has refused to suspend all dosing of its gene therapy for Duchenne muscular dystrophy, Elevidys, defying a clinical hold request from the FDA. The FDA said it had met with Sarepta to ask that ...

Exclusive: Trump's spy chief Gabbard winds down intelligence task force Gabbard told Reuters she has wound down a task force she launched last year with the goal of rooting out politicization from ...